SEC Comment Letter for ChronoScale Holdings Corp (CHRN) (CIK 0001549084) (CHRN) — Mar 27, 2026
ChronoScale Holdings Corp (CHRN) (CIK 0001549084)
Date: March 27, 2026 · CIK: 0001549084 · Accession: 0000000000-26-003125
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-37854
Letter
Re: Ekso Bionics Holdings, Inc. Preliminary Information Statement Filed March 20, 2026 File No. 001-37854 Dear Scott G. Davis:
March 27, 2026
Scott G. Davis Chief Executive Officer Ekso Bionics Holdings, Inc. 101 Glacier Point, Suite A San Rafael , California 94901
We have reviewed your filing and have the following comment.
Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments.
Preliminary Information Statement Opinion of Ekso s Financial Advisor to the Board, page 41
1. We note that in performing its analyses and rendering its fairness opinion, Ekso's financial advisor, Lake Street Capital Markets LLC, relied on, among other things, internal financial analyses and forecasts prepared by Cloud's management. Please disclose the financial projections and other financial information furnished to Lake Street in the information statement. Refer to Item 1015(b)(6) of Regulation M-A. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Matthew Crispino at 202-551-3456 or Jan Woo at 202-551- 3453 with any other questions.
Sincerely,
Division of
Corporation Finance
Office of
Technology
March 27, 2026
Page 2
cc: Austin March
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 27, 2026 Scott G. Davis Chief Executive Officer Ekso Bionics Holdings, Inc. 101 Glacier Point, Suite A San Rafael , California 94901 Re: Ekso Bionics Holdings, Inc. Preliminary Information Statement Filed March 20, 2026 File No. 001-37854 Dear Scott G. Davis: We have reviewed your filing and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Preliminary Information Statement Opinion of Ekso s Financial Advisor to the Board, page 41 1. We note that in performing its analyses and rendering its fairness opinion, Ekso's financial advisor, Lake Street Capital Markets LLC, relied on, among other things, internal financial analyses and forecasts prepared by Cloud's management. Please disclose the financial projections and other financial information furnished to Lake Street in the information statement. Refer to Item 1015(b)(6) of Regulation M-A. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Matthew Crispino at 202-551-3456 or Jan Woo at 202-551- 3453 with any other questions. Sincerely, Division of Corporation Finance Office of Technology March 27, 2026 Page 2 cc: Austin March </TEXT> </DOCUMENT>